29.69
price down icon0.03%   -0.010
after-market Handel nachbörslich: 29.69
loading

Finanzdaten der Caris Life Sciences Inc-Aktie (CAI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
21.99%
263.71
216.17 292.89 216.83 181.40
Research and Development
3.33%
32.36
31.32 31.84 21.62 25.05
Costs And Expenses
12.28%
236.79
210.89 204.47 184.19 199.39
Operating Income/Loss
409.77%
26.93
5.282 88.41 32.64 -17.99
Nonoperating Income/Loss
364.73%
-27.54
-5.926 -6.454 -8.317 -53.80
Income/Loss From Continuing Operations Before Tax
4.66%
-0.614
-0.644 81.96 24.32 -71.79
Income Tax Expense/Benefit
117.16%
0.023
-0.134 - - -
Net Income/Loss
24.90%
-0.637
-0.51 81.96 24.32 -71.79
Basic Average Shares
0.12%
282.89
282.56 - 282.10 64.92
Diluted Average Shares
0.12%
282.89
282.56 - 297.21 64.92
Basic Earnings Per Share
-
- - 0.09 -7.97
Diluted Earnings Per Share
-
- - 0.08 -7.97
$55.27
price down icon 0.18%
$60.73
price down icon 3.22%
$166.00
price down icon 1.40%
$62.79
price down icon 0.19%
$85.90
price up icon 0.25%
$86.94
price down icon 1.37%
Kapitalisierung:     |  Volumen (24h):